Customer Login

About
Pipeline
- Canine Pipeline
- Clinical Trials
Products
- Zimeta^™ (dipyrone injection)
Technology
- Veterinary Recombinant Biologics
- Manufacturing Process
Education
- Continuing Education
- KINections
Investors
News
- Press Releases
Contact Us
- Contact Us
- Careers
Menu

Test PI PDF Embed

You are here: Home / Test PI PDF Embed

Mirataz_Full_PI

News

Kindred Biosciences to Announce First Quarter 2021 Financial ResultsMay 3, 2021 - 9:04 am
Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy IndicationApril 28, 2021 - 8:40 am
Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK StudyApril 20, 2021 - 4:05 pm

Events

Event: Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsMarch 8, 2021 - 8:48 am
Event: Kindred Biosciences to Present at the H.C. Wainwright Global Life Sciences ConferenceMarch 2, 2021 - 8:45 am
Event: Kindred Biosciences to Present at the Barclays Global Healthcare ConferenceMarch 2, 2021 - 8:43 am

$4.63

0.01 (0.22%)

KIN (Common Stock)
Previous Close	Volume
$4.62	292,202
Intraday High	Intraday Low
$4.66	$4.55
52 Week High	52 Week Low
$6.00	$3.20
Exchange: NASDAQ CM

Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements

© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010